PB1849: TRIAL IN PROGRESS: PHASE IB/II STUDY OF SIREMADLIN IN COMBINATION WITH VENETOCLAX + AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WHO ARE INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

Bibliographic Details
Main Authors:	N. G. Daver, A. H. Wei, E. M. Stein, D. J. DeAngelo, D. Pathak, Y. Xu, S. Grzesiak, A. Venditti
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850248.63603.48

Internet